Medical Health Cluster

Variantes Covid

“Battle Of Omicron” Being Won By New BA.4 And BA.5 Variants As Overlapping Covid Waves Hit U.S.

Estimates released by the Centers for Disease Control and Prevention today indicate that the share of cases tied to Omicron variants BA.4 and BA.5 increased 79% in the past week. That means, even as the more transmissible BA.2.12.1 Omicron subvariant became officially dominant in the U.S. last week, it’s already being pushed out by newcomers BA.4 and BA.5. The […]

Read More

COVID-19 Cases, Hospitalizations, and Deaths Among American Indian or Alaska Native Persons — Alaska, 2020–2021

Summary What is already known about this topic? American Indian or Alaska Native (AI/AN) persons across the United States face substantial health disparities, including a disproportionate incidence of COVID-19 illness. What is added by this report? AI/AN persons living in Alaska are at increased risk for COVID-19 illness, COVID-19–associated hospitalization, […]

Read More

COVID-19 capítulo México: “tendencia creciente” de casos, continúa vacunación del grupo de 12 a 17 años

A continuación un resumen de algunos temas destacados sobre SARS-CoV-2 en México del 18 al 31 de mayo. Estado de la pandemia Hasta el 30 de mayo México registra un acumulado de 5’770.862 casos y 324.854 defunciones totales por COVID-19. En la semana del 23 al 30 de mayo se […]

Read More

Novavax Hopes Its COVID Shot Wins Over FDA, Vaccine Holdouts

 Americans may soon get a new COVID-19 vaccine option — shots made with a more tried-and-true technology than today’s versions. The big question: Why should they care? After long delays, the Food and Drug Administration is expected to decide within weeks whether to authorize Novavax’s vaccine. It’s late in the […]

Read More

Moderna says new trial results show that a revised vaccine works better against Omicron.

A significantly stronger immune response against Omicron is seen, but it remains unclear how an updated vaccine will fare against future versions of the virus. Moderna released preliminary results on Wednesday on an updated coronavirus vaccine that targets the Omicron variant, calling it “our lead candidate” to serve as a U.S. booster […]

Read More

H5N1 Avian Influenza: Q&A With the CDC’s Tim Uyeki, MD, MPH, MPP

What is the current state of H5N1 infections among wild and domestic birds in the United States and internationally? In the United States, highly pathogenic avian influenza A(H5N1) virus has been detected in wild birds in 41 states. This includes migratory waterfowl, such as ducks and geese, as well as […]

Read More

The Mystery of Why COVID-19 Rebounds in Some Patients Who Take Paxlovid

David Ho, MD, managed to avoid contracting COVID-19 for more than 2 years. But SARS-CoV-2 finally got the best of the pioneering HIV researcher on an April trip to Paris for, of all things, a 2-day COVID-19 conference. The irony is not lost on Ho, director of the Aaron Diamond […]

Read More

National Academies: US Nursing Home System Needs Fundamental Overhaul

The COVID-19 crisis publicly exposed systemic problems within the US nursing home system, where about 40% of deaths from SARS-CoV-2 infection occurred during the pandemic’s first year. Now, a major report provides a blueprint for overhauling what the authors concluded is an “ineffective, inefficient, fragmented, and unsustainable” approach to long-term and postacute care. […]

Read More

Buenos resultados de seguridad e inmunidad de la dosis de recuerdo con la variante Beta de Sanofi

En un artículo aun en preprint, la farmacéutica Sanofi presenta los resultados de su vacuna adyuvada con AS03 frente al SARS-CoV-2, que incluye la variante beta administrada como dosis de recuerdo en aquellos que recibieron un priming, de 3 a 7 meses antes, con dos dosis de vacuna Comirnaty. Patrocinado por el […]

Read More